U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT06962488) titled 'Clinical Implementation of Blood Pressure Polygenic Risk Score' on April 21.
Brief Summary: In a multi-ethnic population, a genome-wide polygenic risk score (PRS) for systolic blood pressure (SBP), incorporating over one million common genetic variants, predicts blood pressure (BP) traits and the risk of adverse cardiovascular events beyond traditional risk factors. Delivering SBP PRS information to young and middle-aged adults with hypertension (HTN) and poor cardiovascular health (CVH) may enhance their motivation to adopt healthier lifestyles, improve blood pressure control, and ultimately reduce the risk of future cardiovascular d...